PharmaEssentia July revenue jumps 92.6% to NT$2.51 billion

Ropeg sales gained after a U.S. launch in July, while ET filings move toward an Aug. 30, 2026 decision in the U.S. and possible mid-August approval in Japan.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.